Details for New Drug Application (NDA): 071292
✉ Email this page to a colleague
NDA 071292 describes ANTITUSSIVE, which is a drug marketed by Perrigo and is included in one NDA. Additional details are available on the ANTITUSSIVE profile page.
The generic ingredient in ANTITUSSIVE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in ANTITUSSIVE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 071292
| Tradename: | ANTITUSSIVE |
| Applicant: | Perrigo |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071292
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Apr 10, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
